Rodman David Malcom
Chief Medical Officer
3 filings on record here, covering MLYS. Amounts are the ranges the filer reported, which is how the law requires them to be disclosed.
Filings
CORPORATEFiled 2026-08-12
| Exercise | MLYS | Mineralys Therapeutics, Inc. | $34,720 |
| Sell | MLYS | Mineralys Therapeutics, Inc. | $58,785 |
| Exercise | MLYS | Mineralys Therapeutics, Inc. | |
CORPORATEFiled 2026-07-10
| Exercise | MLYS | Mineralys Therapeutics, Inc. | $34,736 |
| Sell | MLYS | Mineralys Therapeutics, Inc. | $65,781 |
| Exercise | MLYS | Mineralys Therapeutics, Inc. | |
CORPORATEFiled 2026-06-17
| Exercise | MLYS | Mineralys Therapeutics, Inc. | $36,128 |
| Sell | MLYS | Mineralys Therapeutics, Inc. | $235,487 |
| Exercise | MLYS | Mineralys Therapeutics, Inc. | $59,380 |
| Exercise | MLYS | Mineralys Therapeutics, Inc. | $6,438 |
| Sell | MLYS | Mineralys Therapeutics, Inc. | $114,600 |
| Exercise | MLYS | Mineralys Therapeutics, Inc. | |
| Exercise | MLYS | Mineralys Therapeutics, Inc. | |
| Exercise | MLYS | Mineralys Therapeutics, Inc. | |
Source records are public filings: House and Senate periodic
transaction reports, Office of Government Ethics filings, and SEC Form 4 filings. Amounts
are reported as ranges by law, not exact figures, and filings arrive on a legal delay.
Eltrove reports what was filed. Nothing here is investment advice or a recommendation.